340B

Mississippi judge denies drug maker’s and PhRMA’s request for preliminary injunction in 340B case
American Hospital Association
Mon, 07/8/24 - 11:35 am
Novartis
PhRMA
340B
legal
Mississippi
Hospitals Are Relying More on PBMs to Manage Manufacturers' 340B Contract Pharmacy Restrictions: DCI's 2024 Market Analysis
Drug Channels
Wed, 06/12/24 - 11:02 am
hospitals
PBMs
340B
drug pricing
Novartis sues Maryland over law mandating discounts for hospitals' outside pharmacies
Reuters
Sun, 06/2/24 - 02:43 pm
Novartis
Maryland
legal
340B
drug discounts
Appeals court sides with drug manufacturers in 340B case
Healthcare Finance News
Wed, 05/22/24 - 10:37 pm
340B
legal
Senator probes Cleveland Clinic, Bon Secours over 340B program
Beckers Hospital Review
Sun, 10/1/23 - 01:24 pm
340B
drug pricing
hospitals
Senate
Cleveland Clinic
The 340B Program Reached $54 Billion in 2022—Up 22% vs. 2021
Drug Channels
Sun, 09/24/23 - 08:49 pm
340B
drug pricing
For 2023, Five For-Profit Retailers and PBMs Dominate an Evolving 340B Contract Pharmacy Market
Drug Channels
Tue, 07/11/23 - 10:05 am
340B
drug pricing
CVS Health
Walgreens
Cigna
Express Scripts
Unitedhealth Group
OptumRx
Walmart
PBMs
Astellas to withhold prostate cancer drug from contract pharmacies
Beckers Hospital Review
Thu, 07/6/23 - 10:03 pm
Astellas
340B
Xtandi
prostate cancer
Teva to stop sending 340B-discounted drugs to contract pharmacies
Beckers Hospital Review
Sun, 06/11/23 - 11:11 pm
Teva Pharmaceutical
340B
drug discounts
The Inflation Reduction Act: 10 Predictions About Market Access and Drug Channels
Drug Channels
Tue, 04/18/23 - 09:55 am
Inflation Reduction Act
drug pricing
340B
Medicare Part D
PhRMA-backed alliance says it wants to 'modernize' the 340B program. Critics say the changes will only limit access
Endpoints
Mon, 03/13/23 - 04:43 pm
340B
PhRMA
J&J to impose new limits on 340B access after industry court win
Endpoints
Wed, 02/22/23 - 06:57 pm
JNJ
340B
legal
AstraZeneca, Novo Nordisk and Sanofi score 340B-related appeals court win over HHS
Endpoints
Mon, 01/30/23 - 05:58 pm
AstraZeneca
Sanofi
Novo Nordisk
340B
drug discounts
The 340B Program Climbed to $44 Billion in 2021—With Hospitals Grabbing Most of the Money
Drug Channels
Tue, 08/16/22 - 10:48 am
drug pricing
340B
hospitals
HRSA
340B entities face increased challenges in a shifting regulatory and enforcement landscape
MedCity News
Thu, 08/11/22 - 11:23 pm
340B
regulatory
How health systems are responding to 340B discount restrictions
Beckers Hospital Review
Mon, 04/18/22 - 11:38 pm
drug discounts
340B
hospitals
Ballooning 340B market reaches almost 15% of 2021 US pharma sales, IQVIA finds
Endpoints
Mon, 04/11/22 - 07:19 pm
IQVIA
340B
The 340B Noncompliance Data Gap Leaves Drug Manufacturers in the Dark
Drug Channels
Fri, 03/18/22 - 10:24 am
340B
Gilead to limit 340B discounts for hepatitis C drugs
Beckers Hospital Review
Wed, 03/16/22 - 11:28 pm
Gilead Sciences
340B
hepatitis B
AstraZeneca scores another industry victory over the federal government in 340B litigation
Endpoints
Thu, 02/17/22 - 11:23 pm
AstraZeneca
Delaware
340B
legal

Pages